Has Daniel Pugliese, MD received payments from drug or device companies?

Yes. Drug and device makers reported $63,300 in general payments to Daniel Pugliese, MD across 307 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Pugliese, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Pugliese, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Pugliese, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1255691549

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (59.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 66.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2021 at $39,022 and has fallen 78.1% since, to $8,530 in 2025.

$63,300in general payments, 2019–2025

Across 307 payments — averaging $206.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$42K
Biotronik Inc.$12K
Medtronic$3K
Boston Scientific$3K
Biosense Webster, Inc.$2K
E.r. Squibb & Sons, L.L.C.$178
plus $869 from 12 others

What the payments were for

Consulting fees$3,7006%
Grants$37,33059%
Travel & lodging$10,48217%
Food & beverage$11,28918%
Education$5001%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	92	$41,942
Biotronik Inc.	46	$12,223
Medtronic(2 entities)	19	$3,490
Boston Scientific	78	$2,743
Biosense Webster, Inc.	32	$1,855
E.r. Squibb & Sons, L.L.C.	8	$178
Cardiva Medical, Inc.	4	$178
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	10	$165
Abiomed	2	$144
AstraZeneca	4	$86
Scpharmaceuticals Inc.	3	$77
Philips North America LLC	2	$67
Boehringer Ingelheim	2	$44
Altathera Pharmaceuticals LLC	1	$30
Bridgebio Pharma, Inc.	1	$21
Sanofi-aventis U.S. LLC	1	$20
Bayer	1	$19
Cordis US CORP.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Assurity Pacemaker$18,270
TactiCath SE$18,000
AVEIR$2,540
Acticor 7 VR-T DX$2,049
Edora 8 DR-T$1,956
Rivacor 7 DR-T$1,816
Carto 3$1,401
EVERA MRI XT DR SURESCAN$1,150
Solia$963
BioMonitor$963
Sentus$853
GENERAL - THERAPIES$401
OCTARAY MAPPING CATHETER$364
NUVISION ICE CATHETER$326
EnSite Precision Cardiac Mapping System$312
AMPLATZER AMULET$274
ASSURITY$239
Fortify Assura$165
AURORA EV-ICD MRI SURESCAN$163
WATCHMAN Access System$142

How this compares

$63,300 in reported general payments places this provider in the 80th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024

$82,536

Medicare patients

612

Services billed

1,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	16	$17,511
Amiodarone Hcl	29	$255

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

Vivek ReddyNew York$14.9M
Jacob KoruthNew York$3.7M
Srinivas DukkipatiNew York$2.7M
Amir AhmadiNew York$789K
Larry ChinitzNew York$448K
James IpNew York$347K
Nicholas SkipitarisNew York$293K
Mohit TuragamNew York$202K
David LauNew York$202K
Christopher LiuNew York$181K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →